We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Recipharm Appoints Prof. Hans Lennernäs to One of its Operating Boards

News   Feb 05, 2013

 
Recipharm Appoints Prof. Hans Lennernäs to One of its Operating Boards
 
 
 

RELATED ARTICLES

Getting Cancer Drugs to the Brain Is Difficult – But New Insights Could Make It Easier

News

Researchers have provided the first comprehensive characterization of the blood-brain and blood-tumor barriers in brain metastases of lung cancer, which will serve as a road map for treatment development.

READ MORE

Vaccine Can Reduce Likelihood of Severe Pneumonia by Up to 35%

News

A new study has found severe pneumonia decreases by 35 per cent in children who receive a vaccine against a pneumonia-causing bacteria.

READ MORE

GW Pharmaceuticals Receives Positive NICE Recommendation for EPIDYOLEX (Cannabidiol)

News

GW Pharmaceuticals plc announces that two of its medicines, EPIDYOLEX (cannabidiol) oral solution and Sativex (nabiximols), have been recommended by the UK’s National Institute for Health and Care Excellence (NICE) to receive routine reimbursement from NHS England.

READ MORE

 

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE